Merck's (MRK) KEYTRUDA Receives FDA Breakthrough Designation

October 27, 2014 6:45 AM

Merck (NYSE: MRK) announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to KEYTRUDA (pembrolizumab) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found